Review of Oral Cholecystographic Agents for the Management of Hyperthyroidism-Reference-Cited by-同舟云学术

Review of Oral Cholecystographic Agents for the Management of Hyperthyroidism

Published:2014-10 Issue:10 Volume:20 Page:1084-1092
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Tyer Nicole M.,Kim Tiffany Y.,Martinez Dorothy S.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Link

http://aace.metapress.com/index/U25201800G3P3446.pdf

Reference73 articles.

1. Observations on a series of aryl triiodo alkanoic acid derivatives with particular reference to a new cholecystographic medium, telepaque;Hoppe;Am J Roentgenol Radium Ther Nucl Med.,1953

2. Oral Cholecystography with Iopanoic Acid;Berk;N Engl J Med.,1974

3. Hyperthyroidism after cholecystography;Fairhurst;Br Med J.,1975

4. Changes of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents;Burgi;J Clin Endocrinol Metab.,1976

5. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography;Wu;J Clin Endocrinol Metab.,1978

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibiting thyroid activation in aged human explants prevents mechanical induced detrimental signalling by mitigating metabolic processes;Rheumatology;2022-04-05

2. Medical treatment of thyrotoxicosis;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2021-04

3. How do I diagnose and manage acute endocrine emergencies in the ICU?;Evidence-Based Practice of Critical Care;2020

4. Amiodarone-induced thyrotoxicosis type 2: predictors and treatment options;Almanac of Clinical Medicine;2019-05-31

5. Thyrotoxicosis; Treatment;Encyclopedia of Endocrine Diseases;2018